Getinge AB (publ) (OTCMKTS:GNGBY) Short Interest Down 12.4% in September

Getinge AB (publ) (OTCMKTS:GNGBYGet Free Report) was the recipient of a large decrease in short interest in the month of September. As of September 15th, there was short interest totalling 9,900 shares, a decrease of 12.4% from the August 31st total of 11,300 shares. Based on an average daily trading volume, of 23,700 shares, the days-to-cover ratio is presently 0.4 days.

Getinge AB (publ) Stock Up 0.2 %

OTCMKTS:GNGBY traded up $0.05 during trading hours on Monday, reaching $21.48. The company’s stock had a trading volume of 8,867 shares, compared to its average volume of 12,463. The business’s 50-day moving average is $20.37 and its 200-day moving average is $19.38. The company has a debt-to-equity ratio of 0.20, a current ratio of 1.67 and a quick ratio of 0.98. Getinge AB has a one year low of $16.71 and a one year high of $22.85. The company has a market cap of $5.85 billion, a price-to-earnings ratio of 27.19 and a beta of 0.82.

Getinge AB (publ) (OTCMKTS:GNGBYGet Free Report) last released its quarterly earnings results on Thursday, July 18th. The company reported $0.21 earnings per share for the quarter. The firm had revenue of $776.85 million during the quarter. Getinge AB (publ) had a return on equity of 8.56% and a net margin of 7.76%.

About Getinge AB (publ)

(Get Free Report)

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, mechanical circulatory support, advanced patient monitoring, ICU infrastructure equipment, patient flow management, and drainage solutions.

Featured Articles

Receive News & Ratings for Getinge AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Getinge AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.